Science - August 8, 2019
Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
The Atlantic - July 15, 2019
Eric Hollander, M.D., comments on how ingesting the eggs of the parasitic worm Trichuris suis may affect the gut microbiome and improve repetitive behavior, rigidity, and irritability in people with autism spectrum disorder. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
CBS New York - July 12, 2019
Richard Lipton, M.D., discusses his New England Journal of Medicine study on rimegepant, a drug belonging to a new generation of acute migraine headache treatments that was found to eliminate pain and reduce bothersome symptoms. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the Montefiore Headache Center.
More CoverageDr. Lipton's ProfileMore coverage on Dr. Lipton
Scientific American - July 3, 2019
Scott Emmons, Ph.D., describes how his publication of the first complete map of an animal’s nervous system may have implications for our understanding of human behavior. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience, and is the Siegfried Ullmann Chair in Molecular Genetics at Einstein.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
BBC News - July 3, 2019
Qibin Qi, Ph.D., discusses his European Heart Journal research that found postmenopausal women with normal BMI who are “apple-shaped” face a greater risk of developing cardiovascular disease than those who are “pear-shaped.” Dr. Qi is associate professor of epidemiology & population health at Einstein.
More CoverageDr. Qi's ProfileMore coverage on Dr. Qi
The Wall Street Journal - July 3, 2019
Parsa Mirhaji, M.D., Ph.D., describes the successful use of artificial intelligence at Montefiore and Einstein to predict acute respiratory failure. Dr. Mirhaji is research associate professor of systems and computational biology at Einstein and director of the Montefiore Einstein Center for Health Data Innovations.
Dr. Mirhaji's Profile
The New York Times - July 3, 2019
Lauren Sydney Flicker, J.D., addresses the ethical considerations of a court ruling allowing the parents of a deceased man to control the disposition of sperm harvested from his body. Ms. Flicker is associate professor of epidemiology and population health at Einstein and associate director of the Montefiore Einstein Center for Bioethics.
Ms. Flicker's ProfileMore coverage on Ms. Flicker
UPI - July 3, 2019
Paul Frenette, M.D., explains his research on a beta blocker that significantly reduced men’s risk of intermediate- and low-grad prostate cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Dr. Frenette's ProfileMore coverage on Dr. Frenette
Associated Press - July 2, 2019
Emad Eskandar, M.D., comments on the risks and regulations that have limited U.S. clinical trials on deep brain stimulation for addiction. Dr. Eskandar is professor and chair of The Leo M. Davidoff Department of Neurological Surgery and the Jeffrey P. Bergstein Chair in Neurological Surgery at Einstein and Montefiore.
Dr. Eskandar's Profile
Scientific American - June 20, 2019
Eric Hollander, M.D., comments on the results of two clinical trials, one of which he led, that found hormone-altering drugs seemed to improve social communication in patients with autism. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
The Wall Street Journal - June 20, 2019
Tia Powell, M.D., explores the new technologies, tools, and services that can help people with dementia remain in their homes longer and avoid going to nursing homes. Dr. Powell is the Shoshana Trachtenberg Frackman Faculty Scholar in Biomedical Ethics and director of the Montefiore Einstein Center for Bioethics.
Dr. Powell's ProfileMore coverage on Dr. Powell